WVU Names Cancer Center Director
Scot C. Remick, M.D., will lead growing research and cancer care effort

MORGANTOWN, W.Va. – Scot C. Remick, M.D., a renowned cancer physician and researcher, has been named director of the Mary Babb Randolph Cancer Center at West Virginia University.

Dr. Remick, currently the associate director for clinical research at the Case Comprehensive Cancer Center, Cleveland, will join the WVU leadership team this summer. He currently holds the Dr. Lester E. Coleman Chair in Cancer Research and Therapeutics at Case Western Reserve University School of Medicine.

“Dr. Remick brings with him a history of compassionate cancer care, dedication to advancement of medicine through clinical research, and strong organizational and institutional leadership,” said John Prescott, M.D., dean of the WVU School of Medicine.

Dr. Prescott has been serving as interim director of the cancer center during the nationwide search for the institution’s next leader.

“We see Dr. Remick as the ideal person to lead the Cancer Center into a new era of growth that will benefit our patients, our state and our hospital,” said Bruce McClymonds, president and CEO of WVU Hospitals.

“It was an easy decision for me and my family to choose to come to Morgantown,” Remick said. “Among the most attractive aspects of this position is the extraordinary energy and commitment of all our partners in the Mary Babb Randolph Cancer Center – including the clinical and research faculty, staff, institutional leadership, and most importantly the residents of Morgantown and countless friends and benefactors throughout the State of West Virginia.  I am convinced the center is poised for great things.”

 Scot C. Remick, M.D., a renowned cancer physician and researcher, has been named director of the Mary Babb Randolph Cancer Center at West Virginia University.

At Case, Remick has been among the physician leaders of a world-class comprehensive cancer center. He has won a number of large, competitive, peer-reviewed research grants from the National Cancer Institute and other funding agencies. He has established relationships with pharmaceutical industry research-funding groups, and has participated in numerous clinical trials. He has been an active participant in national and international cancer research efforts.

Remick has been principal investigator or co-investigator on tens of millions of dollars in externally funded cancer and AIDS research at Case. He is a graduate of New York Medical College, with residency training at Johns Hopkins and fellowship training at the University of Wisconsin Clinical Cancer Center.

“We are excited about Dr. Remick, who is a scientist of international stature, joining MBRCC,” said Jame Abraham, M.D., cancer clinic medical director. “Under his leadership we will be able to build a state of the art cancer center and cancer program in West Virginia."

“We are particularly lucky to have attracted a person who has given such thoughtful study to the role of the patient in the advancement of medical science,” Prescott said.

“Earlier this year, Dr. Remick delivered a grand rounds lecture to a packed house of WVU students and faculty members,” Prescott added.  “His talk, ‘Phase I Trials in Cancer: The Ethics - Efficacy Conundrum,’ helped crystallize for us the moral and medical decision-making process that takes place every time we advise a patient with a life-threatening disease.”

"I am convinced that in Scot Remick the Cancer Center is getting the perfect leader for where we are now -- poised to advance in research and committed to reducing the unequal burden of cancer in our state," said Pamela Brown, the Cancer Center’s director of cancer prevention and control.

The selection of such an accomplished researcher is encouraging to scientists at WVU, said Dan Flynn, Ph.D., the Cancer Center’s deputy director. "Scot Remick brings to the cancer center a wealth of experience in clinical trials.  His expertise and knowledge will help the cancer center integrate research with clinical care, expand our services and offer cutting edge treatment options for our patient populations."

The Mary Babb Randolph Cancer Center is West Virginia’s premier cancer facility, with a national reputation of excellence in cancer treatment, prevention and research. The Cancer Center is in the midst of an unprecedented expansion, with current construction that will double the size of the patient care and research facilities.

The Mary Babb Randolph Cancer Center serves thousands of people from around the state and region, and offer patients access to both well-established treatments and the latest clinical trials of new medications and other cancer treatments. Patients have access to WVU’s advanced imaging center for precise diagnosis.  

Cancer research at WVU is concentrated in three main areas: basic research, which is conducted mostly in the laboratory and explores the cellular and other biological functions of cancer growth; translational research, which involves applying basic research findings in the care of patients; and population-based research, which studies the effects of cancer on large numbers of people and the disparities among social, geographic or ethnic groups in prevalence or mortality from cancer.

Dr. Remick’s first public appearance on the WVU campus is scheduled for June 21, when he will deliver the annual DeLynn Lecture to faculty, students, staff and supporters of the Cancer Center. He will begin his duties as director later in the summer.

- WVU -

For more information:
Steve Bovino, HSC News Service, (304) 293-7087

Return To News Releases